Page last updated: 2024-11-03

rabeprazole and Local Neoplasm Recurrence

rabeprazole has been researched along with Local Neoplasm Recurrence in 1 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Research Excerpts

ExcerptRelevanceReference
"Patients with early gastric cancers that are limited to gastric mucosa or submucosa usually have an advanced loss of mucosal glandular tissue (glandular atrophy) and are at high risk for subsequent (metachronous) development of new gastric cancer."2.87Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer. ( Cho, SJ; Choi, IJ; Kim, CG; Kim, YI; Kook, MC; Lee, JY; Nam, BH; Park, B, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, IJ1
Kook, MC1
Kim, YI1
Cho, SJ1
Lee, JY1
Kim, CG1
Park, B1
Nam, BH1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of Helicobacter Pylori Eradication on Glandular Atrophy and Metachronous Cancer in Patients Undergoing Endoscopic Mucosal Resection for Gastric Cancer[NCT02407119]Phase 3470 participants (Actual)Interventional2003-06-30Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for rabeprazole and Local Neoplasm Recurrence

ArticleYear
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.
    The New England journal of medicine, 2018, Mar-22, Volume: 378, Issue:12

    Topics: Adenoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug

2018